The Drug Enforcement Administration may revoke TruePill’s ability to fill controlled substances over allegations that it wrongly filled thousands of prescriptions for stimulants used to treat attention-deficit/hyperactivity disorder.
Read the full post on Becker's Hospital Review - Healthcare News
